Clinical Trial Update: Ambispective Validation of the Odesa Criteria 2026 (OC26): A Flexible Point-Based System for Diagnosis of Autoimmune Pancreatitis.

View source ↗

Summary

The document describes a planned ambispective validation study of the Odesa Criteria 2026 for diagnosing autoimmune pancreatitis and related IgG4-related diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Pancreatitis
• Igg4-related Disease
• Pancreatic Cancer
• Pancreatitis

Snippet

Sponsor: Military Medical Clinical Center of the Southern Region, Ukraine | Conditions: Autoimmune Pancreatitis, IgG4-Related Diseases | Status: NOT_YET_RECRUITING